Duato discusses the split of the business, dealing with the scrutiny brought about by lawsuits, and 2025 priorities.
Pharmaceutical giant Johnson & Johnson (JNJ) is planning to sell its stroke care business called “Cerenovus” for $1 billion ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback